Ion Beam Applications, SA
Specializes in particle accelerator technology for medical and industrial applications.
IBAB | BR
Overview
Corporate Details
- ISIN(s):
- BE0003766806
- LEI:
- 5493002RVRZ1S3CPUI26
- Country:
- Belgium
- Address:
- Chemin du Cyclotron 3, 1348 Ottignies-Louvain-la-Neuve
- Website:
- https://www.iba-worldwide.com/
- Sector:
- Manufacturing
Description
Ion Beam Applications (IBA) is a global company specializing in particle accelerator technology. It designs, manufactures, and markets advanced solutions for medical and industrial applications. The company is a leading supplier of proton therapy systems for the treatment of cancer. Its portfolio also includes dosimetry and quality assurance solutions for radiation therapy and medical imaging, as well as integrated systems for the production of radiopharmaceuticals (RadioPharma Solutions). Additionally, IBA provides industrial solutions, utilizing electron beam and X-ray accelerators for applications such as medical device sterilization and polymer modification.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-08-26 07:00 |
20220826-IBA-Proton-therapy-Tender-Spain-EN.pdf
|
English | 167.1 KB | ||
| 2022-08-26 07:00 |
20220826-IBA-Appel-Offres-PT-Espagne-FR.pdf
|
French | 197.1 KB | ||
| 2022-06-30 07:00 |
IBA signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton the…
|
English | 171.8 KB | ||
| 2022-06-30 07:00 |
IBA signe un contrat avec l’Istituto Clinico Humanitas pour une solution de pro…
|
French | 172.9 KB | ||
| 2022-06-10 11:01 |
IBA - AGO 2022 - PV - 20220608 - en séance - Clean.pdf
|
French | 268.7 KB | ||
| 2022-06-10 10:57 |
IBA - AGO 08.06.2022-Convocations - 20220503.pdf
|
French | 300.5 KB | ||
| 2022-06-01 07:00 |
IBA signs Proteus®ONE contract with Baptist Health’s Lynn Cancer Institute for …
|
English | 181.6 KB | ||
| 2022-06-01 07:00 |
IBA signe un contrat Proteus®ONE avec Baptist Health’s Lynn Cancer Institute po…
|
French | 183.7 KB | ||
| 2022-05-19 07:00 |
220519-IBA-Q1-Business-Update-EN.pdf
|
English | 230.6 KB | ||
| 2022-05-19 07:00 |
220519-IBA-Declaration-intermediaire-1er-trimestre-2022-FR.pdf
|
French | 188.4 KB | ||
| 2022-05-19 07:00 |
IBA Business Update – First Quarter 2022
|
English | 230.6 KB | ||
| 2022-05-19 07:00 |
Déclaration Intermédiaire – Premier Trimestre 2022
|
French | 188.4 KB | ||
| 2022-05-05 07:00 |
IBA Receives Order from CGNNT for a Proteus®PLUS System to be Installed in Yang…
|
English | 136.8 KB | ||
| 2022-05-05 07:00 |
IBA reçoit une commande de CGNNT pour un système Proteus®PLUS qui sera installé…
|
French | 207.8 KB | ||
| 2022-05-03 07:00 |
IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devic…
|
English | 168.8 KB |
Automate Your Workflow. Get a real-time feed of all Ion Beam Applications, SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ion Beam Applications, SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ion Beam Applications, SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-09-30 | Legrain Olivier | Board | Sell | 25,000 | 332,600.00 EUR |
| 2024-09-30 | Legrain Olivier | Board | Buy | 25,000 | 188,500.00 EUR |
| 2024-07-23 | Scutnaire Bruno | Executive member | Sell | 5,000 | 66,350.00 EUR |
| 2024-06-06 | Scutnaire Bruno | Executive member | Buy | 5,000 | 37,500.00 EUR |
| 2024-04-12 | Van der Burght Marc | Executive member | Sell | 5,000 | 67,722.85 EUR |
| 2024-04-12 | Saint Denis | Board | Sell | 4,000 | 54,073.60 EUR |
| 2024-04-11 | Van der Burght Marc | Executive member | Sell | 9,000 | 122,849.28 EUR |
| 2024-04-04 | Bothy Jean-Marc | Executive member | Sell | 5,000 | 68,908.00 EUR |
| 2024-04-04 | Bothy Jean-Marc | Executive member | Buy | 5,000 | 57,600.00 EUR |
| 2024-03-28 | Saint Denis | Board | Sell | 4,000 | 52,024.00 EUR |
Peer Companies
